CAD 23.06
(0.39%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 49.2 Billion | 47.74 Billion | 42.91 Billion | 36.4 Billion | 38.03 Billion | 36.41 Billion |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | 49.2 Billion | 47.74 Billion | 42.91 Billion | 36.4 Billion | 38.03 Billion | 36.41 Billion |
Operating Expenses | 23.8 Billion | 26.32 Billion | 24.99 Billion | 23.35 Billion | 23.61 Billion | 21.89 Billion |
Selling, General and Administrative Expenses | 23.8 Billion | 20.5 Billion | 18.77 Billion | 18.15 Billion | 17.44 Billion | 15.21 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 23.8 Billion | 26.32 Billion | 24.99 Billion | 23.35 Billion | 23.61 Billion | 21.89 Billion |
Operating Income | 25.39 Billion | 20.79 Billion | 17.84 Billion | 12.71 Billion | 14.2 Billion | 14.66 Billion |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 3.16 Billion | 3.98 Billion | 3.62 Billion | 1.15 Billion | 2.73 Billion | 3.18 Billion |
Earnings before Tax | 13.95 Billion | 21.41 Billion | 17.91 Billion | 13.04 Billion | 14.42 Billion | 14.51 Billion |
Net Income | 10.78 Billion | 17.17 Billion | 14.04 Billion | 11.62 Billion | 11.41 Billion | 11.04 Billion |
Earnings Per Share Basic | 5.31 | 9.47 | 7.72 | 6.43 | 6.25 | 6.01 |
Earnings Per Share Diluted | 5.60 | 9.47 | 7.72 | 6.43 | 6.25 | 6.01 |
Weighted Average Shares Outstanding | 1.92 Billion | 1.81 Billion | 1.81 Billion | 1.8 Billion | 1.82 Billion | 1.83 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.82 Billion | 1.81 Billion | 1.82 Billion | 1.8 Billion | 1.82 Billion | 1.83 Billion |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | -0.05 | 0.01 | -0.00 | 0.00 | -0.00 | -0.01 |
Profit Margin | 0.22 | 0.36 | 0.33 | 0.32 | 0.30 | 0.30 |
EBITDA | -2.37 Billion | 357 Million | -170 Million | 65 Million | -53 Million | -431 Million |
Earnings Before Tax Margin | 0.52 | 0.44 | 0.42 | 0.35 | 0.37 | 0.40 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 13.1 Billion | 13.86 Billion | 11.59 Billion | 13.88 Billion | 49.2 Billion | 12.01 Billion |
Cost of Revenue | - | 2.66 Billion | -1.11 Billion | - | - | - |
Gross Profit | 13.1 Billion | 11.19 Billion | 12.71 Billion | 13.88 Billion | 49.2 Billion | 12.01 Billion |
Operating Expenses | 6.35 Billion | 6.38 Billion | 8.14 Billion | 10.37 Billion | 35.25 Billion | 8.32 Billion |
Selling, General and Administrative Expenses | 6.35 Billion | 6.38 Billion | 6.31 Billion | 6.3 Billion | - | 5.99 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 6.35 Billion | 6.38 Billion | 8.14 Billion | 10.37 Billion | 35.25 Billion | 8.32 Billion |
Operating Income | 6.74 Billion | 7.47 Billion | 3.79 Billion | 5.54 Billion | 15.76 Billion | 3.68 Billion |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 794 Million | 729 Million | 634 Million | 628 Million | 3.16 Billion | 727 Million |
Earnings before Tax | 613 Million | 3.29 Billion | 3.45 Billion | 3.51 Billion | 13.95 Billion | 3.69 Billion |
Net Income | -181 Million | 2.56 Billion | 2.75 Billion | 2.69 Billion | 10.21 Billion | 2.88 Billion |
Earnings Per Share Basic | -0.10 | 1.35 | 1.54 | 1.49 | - | 1.57 |
Earnings Per Share Diluted | -0.10 | 1.45 | 1.55 | 1.49 | - | 1.57 |
Weighted Average Shares Outstanding | 1.9 Billion | 1.9 Billion | 1.78 Billion | 1.8 Billion | 1.82 Billion | 1.84 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.74 Billion | 1.76 Billion | 1.77 Billion | 1.8 Billion | 1.82 Billion | 1.83 Billion |
Gross Margin | 1.00 | 0.81 | 1.10 | 1.00 | 1.00 | 1.00 |
EBIT Margin | 0.52 | -0.02 | -0.04 | -0.16 | - | -0.01 |
Profit Margin | -0.01 | 0.18 | 0.24 | 0.19 | 0.21 | 0.24 |
EBITDA | 6.74 Billion | -329 Million | -409 Million | -2.23 Billion | - | -67 Million |
Earnings Before Tax Margin | 0.52 | 0.54 | 0.33 | 0.40 | 0.32 | 0.31 |
KOG
688110
GALADAFIN
IR5B
OBRN
BGBIO